Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 314

1.

Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells.

Chiu ST, Chang KJ, Ting CH, Shen HC, Li H, Hsieh FJ.

Carcinogenesis. 2009 Sep;30(9):1475-86. doi: 10.1093/carcin/bgp133. Epub 2009 May 29.

PMID:
19483190
2.

Overexpression of endoplasmic reticulum protein 29 regulates mesenchymal-epithelial transition and suppresses xenograft tumor growth of invasive breast cancer cells.

Bambang IF, Xu S, Zhou J, Salto-Tellez M, Sethi SK, Zhang D.

Lab Invest. 2009 Nov;89(11):1229-42. doi: 10.1038/labinvest.2009.87. Epub 2009 Sep 21.

3.
4.

Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.

Bagnato A, Rosanò L.

Cells Tissues Organs. 2007;185(1-3):85-94. Review.

PMID:
17587812
6.

Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.

Mejlvang J, Kriajevska M, Berditchevski F, Bronstein I, Lukanidin EM, Pringle JH, Mellon JK, Tulchinsky EM.

Exp Cell Res. 2007 Jan 15;313(2):380-93. Epub 2006 Oct 26.

PMID:
17141758
7.

CSE1/CAS overexpression inhibits the tumorigenicity of HT-29 colon cancer cells.

Jiang MC, Liao CF.

J Exp Clin Cancer Res. 2004 Jun;23(2):325-32.

PMID:
15354419
8.

In human leukemia cells ephrin-B-induced invasive activity is supported by Lck and is associated with reassembling of lipid raft signaling complexes.

Jiang G, Freywald T, Webster J, Kozan D, Geyer R, DeCoteau J, Narendran A, Freywald A.

Mol Cancer Res. 2008 Feb;6(2):291-305. doi: 10.1158/1541-7786.MCR-07-0047.

9.

EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells.

Cortina C, Palomo-Ponce S, Iglesias M, Fernández-Masip JL, Vivancos A, Whissell G, Humà M, Peiró N, Gallego L, Jonkheer S, Davy A, Lloreta J, Sancho E, Batlle E.

Nat Genet. 2007 Nov;39(11):1376-83. Epub 2007 Sep 30.

PMID:
17906625
10.

Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells.

Yang AD, Camp ER, Fan F, Shen L, Gray MJ, Liu W, Somcio R, Bauer TW, Wu Y, Hicklin DJ, Ellis LM.

Cancer Res. 2006 Jan 1;66(1):46-51.

11.

Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells.

Ghoul A, Serova M, Astorgues-Xerri L, Bieche I, Bousquet G, Varna M, Vidaud M, Phillips E, Weill S, Benhadji KA, Lokiec F, Cvitkovic E, Faivre S, Raymond E.

Cancer Res. 2009 May 15;69(10):4260-9. doi: 10.1158/0008-5472.CAN-08-2837. Epub 2009 May 5.

13.

TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis.

Oft M, Heider KH, Beug H.

Curr Biol. 1998 Nov 19;8(23):1243-52.

14.

TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin alpha5 and its signaling pathways.

Kim S, Kang HY, Nam EH, Choi MS, Zhao XF, Hong CS, Lee JW, Lee JH, Park YK.

Carcinogenesis. 2010 Apr;31(4):597-606. doi: 10.1093/carcin/bgq024. Epub 2010 Jan 29.

PMID:
20118200
15.

Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.

Noren NK, Lu M, Freeman AL, Koolpe M, Pasquale EB.

Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5583-8. Epub 2004 Apr 5.

16.

Silencing of the EPHB3 tumor-suppressor gene in human colorectal cancer through decommissioning of a transcriptional enhancer.

Jägle S, Rönsch K, Timme S, Andrlová H, Bertrand M, Jäger M, Proske A, Schrempp M, Yousaf A, Michoel T, Zeiser R, Werner M, Lassmann S, Hecht A.

Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4886-91. doi: 10.1073/pnas.1314523111. Epub 2014 Mar 18.

17.

The RASSF8 candidate tumor suppressor inhibits cell growth and regulates the Wnt and NF-kappaB signaling pathways.

Lock FE, Underhill-Day N, Dunwell T, Matallanas D, Cooper W, Hesson L, Recino A, Ward A, Pavlova T, Zabarovsky E, Grant MM, Maher ER, Chalmers AD, Kolch W, Latif F.

Oncogene. 2010 Jul 29;29(30):4307-16. doi: 10.1038/onc.2010.192. Epub 2010 May 31.

PMID:
20514026
18.

Peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the beta-catenin/T cell factor (TCF) pathway.

Fujisawa T, Nakajima A, Fujisawa N, Takahashi H, Ikeda I, Tomimoto A, Yonemitsu K, Nakajima N, Kudo C, Wada K, Kubota N, Terauchi Y, Kadowaki T, Nakagama H, Blumberg RS.

J Pharmacol Sci. 2008 Apr;106(4):627-38. Epub 2008 Apr 5.

19.

Effect of indomethacin on E-cadherin and beta-catenin expression in HT-29 colon cancer cells.

Kapitanović S, Cacev T, Antica M, Kralj M, Cavrić G, Pavelić K, Spaventi R.

Exp Mol Pathol. 2006 Feb;80(1):91-6. Epub 2005 Jun 16.

PMID:
15963497
20.

The EphB4 receptor-tyrosine kinase promotes the migration of melanoma cells through Rho-mediated actin cytoskeleton reorganization.

Yang NY, Pasquale EB, Owen LB, Ethell IM.

J Biol Chem. 2006 Oct 27;281(43):32574-86. Epub 2006 Aug 31.

Supplemental Content

Support Center